Isotretinoin – updates to prescribing guidance and survey of services

2025-10-27T11:00:14+00:00

The Commission on Human Medicines (CHM) has endorsed changes to isotretinoin prescribing guidance. In addition, CHM is seeking further information from dermatology services who prescribe isotretinoin to inform any future changes to current risk minimisation measures.